ABP News on MSN
ABP Live Doc Talk: Rethinking Parkinson’s Treatment Through Patient Experience And Recovery Outcomes
To the clinical eye, Parkinson’s Disease is defined by the degradation of dopamine-producing neurons in the substantia nigra.
GlobalData on MSN
Parkinson’s research reaches “pivotal” stage, but barriers remain
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Although Jesse Jackson's cause of death has not been disclosed, the civil rights leader struggled with progressive ...
The symptoms the patient’s son described didn’t fit the usual diagnosis of Parkinson’s disease. The family noted mood changes, including outbursts of anger. When the patient ...
When someone develops a tremor or experiences slowed movements, Parkinson’s disease often comes to mind first. However, several neurological conditions present with remarkably similar symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results